What Governance Questions Should We Answer Before Using Behavioural Monitoring?

Behavioural monitoring is becoming an increasingly vital component in health technology, from patient portals to remote monitoring systems. But before deploying these tools, especially those leveraging cutting-edge AI governance frameworks, organizations must thoughtfully address several governance questions. Failing to do so risks erroneous interpretations of data, privacy violations, and ultimately, harm to patients or users.

Companies like MrQ, known for integrating behavioural signals in gambling platforms to identify early risk, and esteemed institutions like the National Institutes of Health (NIH), which fund research into digital biomarkers of health risk, provide valuable models for harnessing behavioural monitoring responsibly in regulated settings.

Why Behavioural Monitoring Requires Thorough Governance

Unlike static clinical measurements, behavioural risk diffuses gradually through digital interactions. A single event—such as a missed login or a sudden drop in remote monitoring submission—does not inherently indicate "non-compliance" or a problem. Instead, patterns matter more than single events. This concept is well-recognized in industries that rely on behavioural signals as an early warning system.

For example, gambling platforms, including those operated by MrQ, do not flag a user's one-time high bet as problem gambling. Instead, changes over time, frequency, and context are analyzed to detect emerging risk. Applying similar principles in healthcare digital platforms demands robust governance to ensure that we interpret data signals accurately without jumping to stories.

Key Governance Questions Before Deploying Behavioural Monitoring

Before implementing any behavioural monitoring system, especially with AI-driven analytics, ask these crucial questions:

1. What is the purpose of behavioural monitoring, and what evidence supports the chosen signals?

Set a clear objective. Is the goal early identification of health deterioration, adherence support, or safety monitoring? Ground the behavioural signals selected in peer-reviewed evidence or validated models—like NIH-sponsored research on remote monitoring behavioural biomarkers.

2. How do we distinguish signals from stories to avoid misinterpretation?

Maintain a running list of "signals vs stories." Signals are measurable data points (e.g., reduced patient portal activity). Stories are the assumptions or interpretations behind those signals (e.g., the patient is disengaged or unwell). Prioritize gathering more data or human review before concluding.

3. What data retention policies govern behavioural monitoring data?

Determine how long behavioural data is stored, who accesses it, and how it is protected. Compliance with GDPR, HIPAA, and local laws is non-negotiable. Longer retention increases re-identification risk and misuse potential—balance retention against clinical necessity.

4. How is human review integrated into AI or automated alert systems?

Automated flags should not trigger clinical or operational actions without a human-in-the-loop review process. Ship AI features https://barrynames.com/what-healthcare-leaders-can-learn-from-digital-platforms-about-behavioural-risk/ only when reviewers can validate or override alerts, contextualize behavioural changes, and decide next steps.

5. What privacy safeguards exist, and how is patient consent obtained?

Think about it: privacy hand-waving is unacceptable. Explicitly communicate how behavioural data is collected, analyzed, and used. Consent must be informed, dynamic, and revocable. Evaluate privacy impact assessments regularly.

6. How do monitoring systems handle ambiguity and avoid false positives?

Design algorithms and rule sets to minimize alarm fatigue. This requires ongoing validation, threshold calibration, and pattern-focused detection strategies that interpret gradual behavioural risk without overreacting to isolated incidents.

7. Does the system support transparency and explainability?

Dashboards must do more than celebrate clicks or system use—they should explain trends, confusions, and behavioural patterns in understandable language to clinicians and users alike.

8. Is cross-disciplinary governance established?

This includes clinician input, UX experts, data scientists, ethicists, and patient representatives to holistically evaluate risks, usability, and equity concerns.

Lessons from MrQ and NIH on Behavioural Signal Use

MrQ employs behavioural monitoring to identify early indicators of problem gambling. Their approach highlights the importance of pattern recognition rather than event-based decisions. Gambling platforms are tightly regulated, requiring evidence-backed thresholds and transparent appeals processes. Similarly, healthcare behavioural monitoring should embed regulatory rigor and clear patient pathways.

The National Institutes of Health (NIH) funds projects exploring behavioural signals from digital health tools to predict clinical outcomes. Their research underscores the necessity of standardizing evidence quality and prioritizing patient privacy. NIH-affiliated studies often emphasize the need for clinical validation prior to operational use, an imperative that healthcare implementers ignore at their peril.

Integrating Behavioural Monitoring into Patient Portals and Remote Monitoring Systems

Patient portals and remote monitoring systems offer rich data streams that reflect patient engagement, health behavior patterns, and wellbeing signals over time. For example:

• Repeated portal logins combined with message response latency can indicate support needs or emerging health issues.
• Remote monitoring data drop-offs may signal worsening symptoms or technical barriers, but isolated instances require human validation.

Governance must ensure these patterns are interpreted within context, not reduced to binary compliance metrics. It's crucial to ask "what would support look like here?" rather than defaulting to punitive frameworks that blame patients.

Summary Table: Governance Questions and Considerations

Governance Question Considerations Example Reference Purpose & Evidence Base Define clear objectives; Use validated behavioural signals vetted by NIH-type research NIH digital biomarker projects Separating Signals from Stories Maintain lists distinguishing raw data from interpretations UX safety frameworks Data Retention Policies Balance clinical value with privacy laws (GDPR/HIPAA) Health data compliance standards Human Review Integration Include clinicians in AI alert validation to avoid false positives MrQ’s regulated gambling alerts Privacy & Consent Obtain explicit informed consent; conduct privacy impact assessments Healthcare privacy frameworks Ambiguity & False Positives Design algorithms for pattern recognition; calibrate thresholds carefully Adaptive monitoring algorithms Transparency & Explainability Avoid dashboards celebrating clicks without explaining behavioural context UX best practices Cross-Disciplinary Governance Include multidisciplinary input—clinicians, data scientists, patients Health program governance boards

Concluding Thoughts

Behavioural monitoring holds significant promise in healthcare technology, enabling earlier, more nuanced detection of patient needs. Yet with this promise comes responsibility. Governance questions around AI, data retention, human review, and privacy must be answered upfront—not as an afterthought. Learning from the careful, evidence-based approaches of organizations like MrQ and the NIH can help ensure behavioural monitoring systems enhance care without causing unintended harm.

Ultimately, responsible governance creates systems where digital behavioural signals support—not replace—human understanding and compassion. Asking "what would support look like here?" before interpreting every pattern ensures we prioritize patients’ dignity as we embrace the future of connected care.